Johns Hopkins has pioneered methods to 'purge' or remove tumor cells from autologous transplants, as well as methods to reduce relapse similar to the allogeneic GVL effect. A critical aspect of the BMT program at Johns Hopkins is the Graft Engineering Laboratory. This laboratory processes all stem cell products for transplantation, and is a world-renowned leader in innovative approaches for improving the safety and efficacy of stem cell products. The nursing staff is highly trained in the care of BMT patients and in critical care. The units are capable of providing conventional and intensive care.
All rooms are private with special air-filtering to decrease the risk of infections.
Some patients undergoing BMT now receive their transplants as outpatients in our new IPOP unit. Click here for information about outpatient transplantation in our new IPOP unit. BMT Faculty Dr. Richard Jones is the director of the Bone Marrow Transplant Unit. Dr. Jones attends on the inpatient unit. His major interests are CML, MDS, and aplastic anemia.